Drug Shortage Report for PMS-RISEDRONATE

Last updated on 2018-11-29 History
Report ID 59125
Drug Identification Number 02302209
Brand name PMS-RISEDRONATE
Common or Proper name RISEDRONATE
Company Name PHARMASCIENCE INC
Market Status MARKETED
Active Ingredient(s) RISEDRONATE SODIUM
Strength(s) 35MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-09-13
Actual start date 2018-09-19
Estimated end date 2018-10-24
Actual end date 2018-11-28
Shortage status Resolved
Updated date 2018-11-29
Company comments RESOLVED
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2018-08-24 English Compare
v2 2018-08-24 French Compare
v3 2018-09-14 English Compare
v4 2018-09-19 English Compare
v5 2018-09-19 French Compare
v6 2018-09-20 English Compare
v7 2018-10-03 English Compare
v8 2018-10-03 French Compare
v9 2018-11-29 English Compare
v10 2018-11-29 French Compare
v11 2018-11-29 French Compare

Showing 1 to 11 of 11